Literature DB >> 26149135

Effects of Estrogen on Insulin Sensitivity and Adipokines in Mice.

Tao Yuan1, Juan Li1, Wei-Gang Zhao1, Yong Fu1, Shuai-Nan Liu2, Quan Liu3, Zhu-Fang Shen3.   

Abstract

OBJECTIVE: To study the potential mechanisms via which estrogen exerts its effects on the insulin sensitivity in mice.
METHODS: Totally 36 female C57BL/6J mice aged 6 weeks were randomly divided into six groups:normal diet (NOR) group, normal diet with ovariectomy (NOR+OVX) group, normal diet with ovariectomy and estrogen replacement (NOR+OVX+E2) group,high-fat diet (HF) group, high-fat diet with ovariectomy (HF+OVX) group, and high-fat diet with ovariectomy and estrogen replacement (HF+OVX+E2) group. There were six mice in each group. After the ovariectomy based on the grouping, the mice were given normal diet or high-fat diet for 20 weeks. The intervention groups were given estrogen (5 μg/d,subcutaneous injection) for 20 days. Then,the body weight,visceral fat weight,oral glucose tolerance and insulin sensitivity (by euglycemic hyperinsulinemic clamp test), and serum leptin, adiponectin,and resistin levels were compared among these six groups.
RESULTS: Compared with HF group, the HF+OVX group had significantly higher body weight and visceral fat weight and lower glucose tolerance, which were significantly improved after estrogen replacement therapy (all P<0.05). However, these indicators showed no significant differences among groups with normal diets (all P>0.05). The insulin sensitivity of ovariectomized mice was significantly decreased in both high-fat and normal diet groups and was also improved significantly after estrogen replacement (P<0.05). The serum leptin was increased and adiponectin was decreased significantly in ovariectomized mice, and the improvements of these two adipokines were also statistically significant after estrogen therapy (P<0.05): however,the serum resistin level was not significantly different among these 6 groups (P>0.05).
CONCLUSIONS: Estrogen replacement therapy can improve insulin resistance by lowering body weight. In addition, it can exert its effect directly on adipose tissue,improve the levels of adipokines,reduce the amount of visceral fat, and improve insulin sensitivity in mice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26149135     DOI: 10.3881/j.issn.1000-503X.2015.03.004

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  5 in total

Review 1.  Hypothalamic Estrogen Signaling and Adipose Tissue Metabolism in Energy Homeostasis.

Authors:  Valeria C Torres Irizarry; Yuwei Jiang; Yanlin He; Pingwen Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

2.  Estrogen receptor α activation modulates the gut microbiome and type 2 diabetes risk factors.

Authors:  Janelle A Shiffler; Krista A Goerger; Brittany K Gorres-Martens
Journal:  Physiol Rep       Date:  2022-06

3.  Ovariectomy uncouples lifespan from metabolic health and reveals a sex-hormone-dependent role of hepatic mTORC2 in aging.

Authors:  Sebastian I Arriola Apelo; Amy Lin; Jacqueline A Brinkman; Emma Meyer; Mark Morrison; Jay L Tomasiewicz; Cassidy P Pumper; Emma L Baar; Nicole E Richardson; Mohammed Alotaibi; Dudley W Lamming
Journal:  Elife       Date:  2020-07-28       Impact factor: 8.140

4.  Removal of melatonin receptor type 1 signalling induces dyslipidaemia and hormonal changes in mice subjected to environmental circadian disruption.

Authors:  Cynthia Tchio; Kenkichi Baba; Giuseppe Piccione; Gianluca Tosini
Journal:  Endocrinol Diabetes Metab       Date:  2020-09-10

5.  Relationship Between Circulating Metabolic Hormones and Their Central Receptors During Ovariectomy-Induced Weight Gain in Rats.

Authors:  Kaitlin E Burch; Kelly McCracken; Daniel J Buck; Randall L Davis; Dusti K Sloan; Kathleen S Curtis
Journal:  Front Physiol       Date:  2022-01-05       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.